CD38 and B-cell chronic lymphocytic leukemia: In another gene expression analysis, NCKAP1L was found to be significantly overexpressed in B-cell chronic lymphocytic leukemia (CLL) cells expressing high CD38, a cell marker associated with poor clinical outcome.